US Food and Drug Administration is investigating charge that St. Jude medical devices can be exploited by hackers.
The US Food and Drug Administration (FDA) is conducting a probe into allegations by short-selling company Muddy Waters and cybersecurity firm MedSec Holdings that pacemakers and defibrillators manufactured by St. Jude Medical have cybersecurity defects and can be exploited by hackers, reports Reuters.
"Regardless of the way a vulnerability comes to our attention, we take those allegations very, very seriously," said FDA official Suzanne Schwartz.
According to the news agency, the charge by Muddy Waters goes against FDA draft guidelines that researcheres should report security vulnerablities to the manufacturer.
St. Jude has sued the companies and rejected their claims of security flaws.
Read more on Reuters.
Read more about:
2016About the Author(s)
You May Also Like
The fuel in the new AI race: Data
April 23, 2024Securing Code in the Age of AI
April 24, 2024Beyond Spam Filters and Firewalls: Preventing Business Email Compromises in the Modern Enterprise
April 30, 2024Key Findings from the State of AppSec Report 2024
May 7, 2024Is AI Identifying Threats to Your Network?
May 14, 2024
Black Hat USA - August 3-8 - Learn More
August 3, 2024Cybersecurity's Hottest New Technologies: What You Need To Know
March 21, 2024